Jazz Pharmaceuticals plc
JAZZ· Nasdaq
Released Jul 31, 2024, after the close
10-Q filed Aug 1, 2024, 32 days after period end · 0001232524-24-000068
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Revenue | $1.02B | $957.32M | $932.88M | $751.81M |
| Net Income | $168.57M | $104.44M | $34.67M | -$363.32M |
| EPS Diluted |
Jazz Pharmaceuticals plc · CIK 1232524 · Engraved from SEC EDGAR
| $2.49 |
| $1.52 |
| $0.55 |
| -$6.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.